PillPack admitted to dispensing more insulin pens than patients needed according to their prescriptions, as well as falsely underreporting the days of supply of insulin dispensed, according to a Justice Department news release.
Prosecutors said PillPack would dispense insulin pens in five-pen cartons, even if this meant patients were receiving a larger supply of insulin than allowed by government-run health insurance programs.
PillPack billed for the entire carton to avoid having its claims denied and would falsely underreport how many days’ supply of insulin the patient received, according to the complaint. Prosecutors said PillPack would also dispense refills before patients needed them based on the falsely reported days of supply.
The complaint did not allege that PillPack overcharged patients.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.